Archive for February, 2008

Recent Study Shows Lack Of Specific Gene Plays Role In Autism

Wednesday, February 20th, 2008

Autism is a brain development disorder characterized by impaired social interaction and communication, and by restricted and repetitive behavior which begin before a child is three years old.

A recent study at Case Western Reserve University found mutations within the ERK ((extracellular signal regulated kinase) signaling pathway appeared to be a common cause for NCFC (neuro-craniofacial-cardiac syndromes) syndromes as well as children with autism due to genetic changes in chromosome 16.

The study, led by Gary Landreth, professor of neurosciences and neurology at the School of Medicine, revealed that was 1 percent of autistic children have either a loss or duplication in a region of Chromosome 16 that encompasses the gene for ERK 1.

Cardiovascular Disease

Saturday, February 16th, 2008

Heart attack – post myocardial infarction
Congestive Heart Failure (CHF)
Atherosclerosis
Severe angina
Stroke
Peripheral Arterial Disease (PAD)
Leg ulcers

Cardiovascular disease, often referred to as “heart disease”, describes a broad range of conditions that affects both the heart and the blood vessels. Heart disease is the number one killer of both men and women worldwide. Every thirty-three seconds in the United States, a person dies from cardiovascular disease.

Conditions typically involve the narrowing or blockage of arteries that bring blood to the heart (coronary arteries), brain (carotid arteries), or the lower limbs (femoral arteries) which can lead to heart attacks, chest pain, angina, stroke or peripheral arterial disease.

Other conditions such as infections, non-controlled high blood pressure or longstanding use of certain medications and drugs can impair the ability of the heart to pump correctly, resulting in congestive heart failure.

Physicians and scientists recognize that myocardial regeneration is possible and attainable. Endothelial progenitors cells (EPCs), show great promise and there is accumulating evidence that these cells can play an important role in vascular repair. These progenitor cells can be mobilized into the peripheral blood through the injections of specific growth factor. (The same cells are also present in the umbilical cord blood.)

Cellulogix offers stem cell treatment for cardiovascular diseases with the collection of peripheral blood stem cells through aphaeresis. The final procedure is non-invasive and consist of an intravenous infusion of precursors of cardiovascular stem cells.

Cell therapy is combined with a holistic comprehensive approach. The entire treatment takes five days to complete and includes lifestyle and diet recommendations, personalized natural supplements, prescriptions for atherosclerosis reduction, and cardiovascular protection.

Post stem cell treatment, patients are asked to submit laboratory tests and studies for cardiac function follow up.